Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=29482389
&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\29482389
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 J+Enzyme+Inhib+Med+Chem
2018 ; 33
(1
): 546-557
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Anticancer evaluation and molecular modeling of multi-targeted kinase inhibitors
based pyrido 2,3-d pyrimidine scaffold
#MMPMID29482389
Elzahabi HSA
; Nossier ES
; Khalifa NM
; Alasfoury RA
; El-Manawaty MA
J Enzyme Inhib Med Chem
2018[Dec]; 33
(1
): 546-557
PMID29482389
show ga
An efficient synthesis of substituted pyrido[2,3-d]pyrimidines was carried out
and evaluated for in vitro anticancer activity against five cancer cell lines,
namely hepatic cancer (HepG-2), prostate cancer (PC-3), colon cancer (HCT-116),
breast cancer (MCF-7), and lung cancer (A-549) cell lines. Regarding HepG-2,
PC-3, HCT-116 cancer cell lines,
7-(4-chlorophenyl)-2-(3-methyl-5-oxo-2,3-dihydro-1H-pyrazol-1-yl)-5-(p-tolyl)-
pyrido[2,3-d]pyrimidin-4(3H)-one (5a) exhibited strong, more potent anticancer
(IC(50): 0.3, 6.6 and 7?然) relative to the standard doxorubicin (IC(50): 0.6,
6.8 and 12.8?然), respectively. Kinase inhibitory assessment of 5a showed
promising inhibitory activity against three kinases namely PDGFR ?, EGFR, and
CDK4/cyclin D1 at two concentrations 50 and 100?然 in single measurements.
Further, a molecular docking study for compound 5a was performed to verify the
binding mode towards the EGFR and CDK4/cyclin D1 kinases.